Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 18/20 | 0.72 |
| ▸ | CNR1 | P21554 | 14/20 | 0.72 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.72 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.72 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.72 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.72 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.72 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.72 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.72 |
| ▸ | HTR2A | P28223 | 1/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.72 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.72 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.72 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.72 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31103606 | 1.00 | CNR2 (0.72) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29330752 | 0.93 | CNR2 (0.70) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL31103589 | 0.93 | CNR2 (0.70) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL17414517 | 0.90 | CNR2 (0.69) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL16002388 | 0.88 | CNR2 (0.66) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL22597777 | 0.88 | CNR2 (0.66) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29976337 | 0.87 | CNR2 (0.78) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL13214142 | 0.87 | CNR2 (0.78) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL15994913 | 0.87 | CNR2 (0.64) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL22597781 | 0.86 | CNR2 (0.63) | CNR2CNR1TRPA1TRPV1TRPV3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210315837-A1 | CANNABINOIDS FOR THE TREATMENT OF GRAM-POSITIVE INFECTIONS INCLUDING ANTIBIOTIC-RESISTANT BACTERIAL STRAINS | NEMUS BIOSCIENCE, INC. | 2021-10-14 | — | — | US | claimed |
| EP-3846616-A1 | CANNABINOIDS FOR THE TREATMENT OF GRAM-POSITIVE INFECTIONS INCLUDING ANTIBIOTIC-RESISTANT BACTERIAL STRAINS | NEMUS BIOSCIENCE, INC. (US) | 2021-07-14 | — | — | EP | claimed |
| US-20220162180-A1 | CANNABINOL-O-ACETATE SYNTHESIS, COMPOSITIONS, AND METHODS OF USE | Marquette Analytica (US) | 2022-05-26 | — | — | US | disclosed |
| US-20210315837-A1 | CANNABINOIDS FOR THE TREATMENT OF GRAM-POSITIVE INFECTIONS INCLUDING ANTIBIOTIC-RESISTANT BACTERIAL STRAINS | NEMUS BIOSCIENCE, INC. | 2021-10-14 | — | — | US | disclosed |
| EP-3846616-A1 | CANNABINOIDS FOR THE TREATMENT OF GRAM-POSITIVE INFECTIONS INCLUDING ANTIBIOTIC-RESISTANT BACTERIAL STRAINS | NEMUS BIOSCIENCE, INC. (US) | 2021-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162180-A1 | CANNABINOL-O-ACETATE SYNTHESIS, COMPOSITIONS, AND METHODS OF USE | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.